Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

HSY to Report Q3 Earnings: Should You Expect a Beat This Time?
HSY to Report Q3 Earnings: Should You Expect a Beat This Time?

The Hershey Company HSY is likely to register an increase in the top line when it reports third-quarter 2025 earnings on Oct. 30. The Zacks Consensus Estimate for Hershey’s quarterly revenues is

Do Options Traders Know Something About ResMed Stock We Don't?
Do Options Traders Know Something About ResMed Stock We Don't?

Investors in ResMed Inc. RMD need to pay close attention to the stock based on moves in the options market lately. That is because the Jan. 16, 2026 $155.00 Call had some of the highest implied

KMB to Report Q3 Earnings: Should You Expect a Beat This Time?
KMB to Report Q3 Earnings: Should You Expect a Beat This Time?

Kimberly-Clark Corporation KMB is likely to register a decrease in both top and bottom lines when it reports third-quarter 2025 earnings on Oct. 30. The Zacks Consensus Estimate for Kimberly-Clark’s

Here's What Key Metrics Tell Us About BCB Bancorp (BCBP) Q3 Earnings
Here's What Key Metrics Tell Us About BCB Bancorp (BCBP) Q3 Earnings

For the quarter ended September 2025, BCB Bancorp (BCBP) reported revenue of $26.46 million, up 1.1% over the same period last year. EPS came in at $0.22, compared to $0.36 in the year-ago quarter.

Should Sprouts Farmers Stock Be in Your Portfolio Pre-Q3 Earnings?
Should Sprouts Farmers Stock Be in Your Portfolio Pre-Q3 Earnings?

With Sprouts Farmers Market, Inc. SFM set to announce its third-quarter 2025 earnings results on Oct. 29, after the market closes, investors are faced with a crucial decision: Should you add SFM to

Willis Towers Gears Up to Report Q3 Earnings: Here's What to Expect
Willis Towers Gears Up to Report Q3 Earnings: Here's What to Expect

Willis Towers Watson Public Limited Company WTW is expected to register an improvement in its bottom line but a decline in the top line when it reports third-quarter 2025 results on Oct. 30, before

UDR Set to Report Q3 Earnings: What's in Store for the Stock?
UDR Set to Report Q3 Earnings: What's in Store for the Stock?

UDR Inc. UDR, a premier multifamily real estate investment trust (REIT), is set to announce its third-quarter 2025 results after the closing bell on Oct. 29. Its quarterly results are likely to

Pre-markets Pick Up Where They Left Off Last Week
Pre-markets Pick Up Where They Left Off Last Week

Monday, October 27, 2025Pre-market futures continue their ascent to start a new week of trading, despite starting slowly with new data, either for Q3 earnings or economic reports. The Dow is +246

Emerging Market ETF (EMCS) Hits Fresh 52-Week High
Emerging Market ETF (EMCS) Hits Fresh 52-Week High

For investors seeking momentum, the Xtrackers MSCI Emerging Markets Climate Selection ETF (EMCS) is probably on the radar now. The fund just hit a 52-week high and is up 48.3% from its 52-week low

Dayforce to Report Q3 Earnings: What's in Store for the Stock?
Dayforce to Report Q3 Earnings: What's in Store for the Stock?

Dayforce DAY is scheduled to release third-quarter 2025 results on Oct. 29.For the to-be-reported quarter, DAY expects revenues to be between $476 million and $486 million. Excluding float, total

Stride to Report Q1 Earnings: Time to Buy or Sell This School Stock?
Stride to Report Q1 Earnings: Time to Buy or Sell This School Stock?

Stride, Inc. LRN is scheduled to report its first-quarter fiscal 2026 results on Oct. 28, after market close.In the last reported quarter, the company’s adjusted earnings per share (EPS) and total

Why Procter & Gamble Remains a Buy-and-Hold Favorite
Why Procter & Gamble Remains a Buy-and-Hold Favorite

Procter & Gamble (NYSE: PG) is a good bet for long-term total returns because its stock price is near the low end of its historical P/E range, its yield is near the high end of its range, and

Is Build-A-Bear's Asset-Light Model the Key to Sustainable Growth?
Is Build-A-Bear's Asset-Light Model the Key to Sustainable Growth?

Build-A-Bear Workshop, Inc.’s BBW asset-light strategy is emerging as a key driver of its growth momentum. The company’s partner-operated retail model is enabling rapid international expansion

Opendoor or Zillow: Which Housing Tech Stock Deserves a Buy Today?
Opendoor or Zillow: Which Housing Tech Stock Deserves a Buy Today?

The U.S. housing market remains challenged by high mortgage rates, affordability pressures and uneven buyer sentiment. Yet within this landscape, Opendoor Technologies OPEN and Zillow Group Z

DRD vs. GFI: Which Gold-Mining Stock is the Better Buy Right Now?
DRD vs. GFI: Which Gold-Mining Stock is the Better Buy Right Now?

DRDGOLD Ltd. DRD and Gold Fields Ltd. GFI are two prominent South Africa–based gold mining companies, each playing distinct roles in the global gold industry. DRD operates primarily in the niche

RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised
RVTY Q3 Earnings Beat, Sales In Line, '25 EPS View Raised

Revvity, Inc. RVTY reported third-quarter 2025 adjusted earnings per share (EPS) of $1.18, which beat the Zacks Consensus Estimate of $1.14 by 3.5%. The bottom line, however, declined 7.8% from the

Eni Q3 Earnings & Revenues Beat on Higher Hydrocarbon Production
Eni Q3 Earnings & Revenues Beat on Higher Hydrocarbon Production

Eni S.p.A E reported third-quarter 2025 adjusted earnings from continuing operations of 90 cents per American Depository Receipt, which beat the Zacks Consensus Estimate of 73 cents. The bottom line

Vertex (VERX) Earnings Expected to Grow: Should You Buy?
Vertex (VERX) Earnings Expected to Grow: Should You Buy?

Vertex (VERX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known consensus outlook gives

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Vertex Pharmaceuticals (VRTX) reports results for the quarter ended September 2025. While this widely-known

TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
TG Therapeutics (TGTX) Earnings Expected to Grow: What to Know Ahead of Q3 Release

Wall Street expects a year-over-year increase in earnings on higher revenues when TG Therapeutics (TGTX) reports results for the quarter ended September 2025. While this widely-known consensus

QuinStreet (QNST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
QuinStreet (QNST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

The market expects QuinStreet (QNST) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025. This widely-known

Transcat, Inc. (TRNS) Reports Next Week: Wall Street Expects Earnings Growth
Transcat, Inc. (TRNS) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Transcat, Inc. (TRNS) reports results for the quarter ended September 2025. While this widely-known consensus

Palomar (PLMR) to Report Q3 Results: Wall Street Expects Earnings Growth
Palomar (PLMR) to Report Q3 Results: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Palomar (PLMR) reports results for the quarter ended September 2025. While this widely-known consensus outlook is

Krystal Biotech, Inc. (KRYS) Reports Next Week: Wall Street Expects Earnings Growth
Krystal Biotech, Inc. (KRYS) Reports Next Week: Wall Street Expects Earnings Growth

The market expects Krystal Biotech, Inc. (KRYS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?
Palantir Technologies Inc. (PLTR) Earnings Expected to Grow: Should You Buy?

The market expects Palantir Technologies Inc. (PLTR) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This